Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

HISTORICAL FACTS: Alembic pharma gets usfda nod for generic influenza treatment drug - Caught on Camera

New Delhi: Alembic Pharmaceuticals Ltd on Friday said it has received final approval from the US health regulator for its generic version of oseltamivir phosphate for oral suspension indicated for treatment of influenza.

The final approval by the US Food & Drug Administration (USFDA) is for the Abbreviated New Drug Application (ANDA) oseltamivir phosphate for oral suspension of strength 6 mg/ml, Alembic Pharmaceuticals said in a regulatory filing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.